TOPOFEN Migraine Therapy Phase II Clinical Trial Results
Saturday, April 25, 2015 - 13:00
in Health & Medicine
A Phase IIa placebo-controlled clinical trial of TOPOFEN, a topical anti-migraine therapy for moderate and severe migraine sufferers, showed that the application of a well-known non-steroidal anti-inflammatory drug (NSAID) over the trigeminal nerve branches can be a safe and effective alternative treatment for patients suffering from acute migraine. read more